Economic aspects of commercial manufacture of biopharmaceuticals.

@article{Werner2004EconomicAO,
  title={Economic aspects of commercial manufacture of biopharmaceuticals.},
  author={Rolf G{\"u}nter Werner},
  journal={Journal of biotechnology},
  year={2004},
  volume={113 1-3},
  pages={171-82}
}
Sustained approvals of new biopharmaceuticals supported by a sparkling pipeline are the drivers for the above-market growth of biopharmaceuticals. Due to usually high therapeutic dose of monoclonal antibodies, they are demanding for high capacity needs. This requires significant capital investment and stimulates innovation for process improvement to decrease cost of goods and to save capital investments. Such process improvements are either ongoing along the learning curve or result from… CONTINUE READING